Overview
ISO/TS 16766:2024 is a Technical Specification that provides manufacturers with guidance on the minimum requirements for lifecycle management of in vitro diagnostic (IVD) medical devices developed in preparation for and response to a public health emergency (infectious agents requiring immediate availability of authorized IVDs). It covers pre‑market through post‑market activities to help accelerate safe deployment of emergency‑use IVDs while recognizing that national or regional regulatory authorization remains country‑specific.
Key Topics
This standard addresses practical technical and quality topics manufacturers must consider when developing emergency‑use IVDs, including:
- Design & development considerations
- Safety and performance requirements
- Target condition and scientific validity
- Assay technology selection and intended use statements
- Quality and risk management
- Integration with quality management systems and risk management processes (design to deployment)
- Risk reduction measures for emergency use scenarios
- Analytical and clinical performance
- Requirements and expectations for analytical performance, clinical performance studies and stability evidence
- Stability and shelf‑life
- Guidance on stability data considerations relevant to accelerated pathways
- Post‑market monitoring & quality assurance
- Monitoring device performance, handling complaints and implementing corrective actions during an emergency
- Communication processes
- Establishing and maintaining manufacturer responsibility for clear, timely communications with regulators, health authorities and users
Applications and Users
ISO/TS 16766:2024 is intended for organizations involved in the lifecycle of IVDs intended for emergency deployment, including:
- IVD manufacturers and product development teams preparing emergency‑use devices
- Regulatory affairs and quality managers managing accelerated authorization pathways
- Clinical performance study teams and laboratory partners conducting validation
- Post‑market surveillance and complaint handling teams
- Public health agencies and procurement bodies seeking harmonized manufacturer expectations during outbreaks
Practical use cases include preparing documentation for emergency authorization, designing risk‑based stability plans, setting up rapid post‑market monitoring, and establishing communication protocols for emergent product issues.
Related Standards
Useful companion documents referenced or relevant to implementers:
- ISO 13485 (quality management for medical devices)
- ISO 20916 (clinical performance study concepts for IVDs)
- ISO 18113‑1 (labelling and intended use terminology)
Implementers should follow national emergency regulatory pathways in parallel with guidance in ISO/TS 16766:2024.
Keywords: ISO/TS 16766:2024, in vitro diagnostic, IVD, public health emergency, emergency‑use IVD, lifecycle management, risk management, post‑market surveillance, analytical performance.